Enhancement of antitumor therapy with hemoglobin-based...

Details Enhancement of antitumor therapy with hemoglobin-based... Enhancement of antitumor therapy with hemoglobin-based...

A - Human Necessities

61

K

A61K 38/42 (2006.01) A61K 47/48 (2006.01) C07K 14/805 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2185433

The use of hemoglobin-polymer conjugates to enhance antitumor therapy in mammals is disclosed. The methods include administering an effective amount of an antitumor therapy such as radiation in combination with hemoglobin conjugated to a substantially non-antigenic polymer.

On potentialise la thérapie antitumorale chez des mammifères en utilisant des conjugués à base d'hémoglobine. Ces procédés thérapeutiques consistent à administrer une dose efficace d'une thérapie antitumorale telle que la radiothérapie, en association avec de l'hémoglobine conjuguée à un polymère sensiblement non antigénique.

Affiliated with

Also associated with

Rating

Enhancement of antitumor therapy with hemoglobin-based... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancement of antitumor therapy with hemoglobin-based..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of antitumor therapy with hemoglobin-based... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1469143